RecruitingPsoriasis
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
Eligible age
18–70 yrs
Accepts
All genders
Locations
11 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
A Study looking at the safety and efficacy of D-2570 in Participants with Plaque Psoriasis
Sponsor: InventisBio Co., Ltd
You may qualify if…
- ✓ Participants with a diagnosis of plaque psoriasis with no significant flares of disease activity for at least 6 months before signing the informed consent
- ✓ Participants have moderate to severe plaque psoriasis as defined by a total body surface area (BSA) ≥10%, a Psoriasis Area and Severity Index (PASI) score ≥ 12 and a Physician's Global Assessment (PGA) score ≥ 3.
- ✓ Within normal ranges of laboratory assessments
You may not qualify if…
- ✕ Any comorbidities or past medical conditions as outlined in the protocol that would interfere with study assessments as deemed by the Investigator
Where it's recruiting
Source: ClinicalTrials.gov · NCT07489885 · last updated 2026-07-09